BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 38528654)

  • 21. The regulatory pathways leading to stem-like cells underlie prostate cancer progression.
    Lin CJ; Lo UG; Hsieh JT
    Asian J Androl; 2019; 21(3):233-240. PubMed ID: 30178777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of extracellular vesicles in castration-resistant prostate cancer.
    Liao C; Huang Z; Liu J; Deng M; Wang L; Chen Y; Li J; Zhao J; Luo X; Zhu J; Wu Q; Fu W; Sun B; Zheng J
    Crit Rev Oncol Hematol; 2024 May; 197():104348. PubMed ID: 38588967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.
    Dwina Y; Zaid LSM; Saraswati M; Rachmadi L; Kekalih A; Rahadiani N; Louisa M; Agustina H; Mochtar CA; Hamid ARAH
    Prostate; 2024 Jun; 84(8):738-746. PubMed ID: 38528654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
    Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
    Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials.
    Ebrahimi S; Hashemy SI; Sahebkar A; Aghaee Bakhtiari SH
    Curr Mol Pharmacol; 2021 Oct; 14(4):559-569. PubMed ID: 33357209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.